Skip to main content
Premium Trial:

Request an Annual Quote

Genomatica, DSM Sign Multi-Year Collaboration, Licensing Agreement

NEW YORK, June 28 (GenomeWeb News) - Genomatica has signed a multi-year collaboration and licensing agreement with DSM, the firm said yesterday.

 

Under the terms of the agreement, Genomatica will provide DSM, a Dutch chemical and biotechnology firm, with its metabolic modeling and simulation technologies.

 

The pact builds on an earlier agreement between the two companies, and includes research and development support, technology license fees, and milestone payments. Financial details were not disclosed. 

 

Christophe Schilling, president and chief scientific officer at Genomatica, said in a statement that the company will provide integrated metabolic engineering solutions to DSM "for developing next-generation microbial bio-factories to produce valuable industrial products from sustainable feedstocks." 

 

DSM sells ingredients based on fermentation and enzyme technology to the chemical, pharmaceutical, and food industries.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.